RxDoctor Payments Data

Becky Ashley, MD

Family Medicine · Gaylord, MINPI 1427080381

Payments from drug & device makers

$978in general payments, 2019–2025

Across 68 payments — averaging $14.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$246
  • Amgen$209
  • Sunovion Pharmaceuticals Inc.$96
  • AstraZeneca$93
  • Pfizer$92
  • AbbVie$62
  • plus $180 from 7 others

What the payments were for

  • Food & beverage$87289%
  • Education$10611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$978 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$106,937
Medicare patients
162
Services billed
2,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide44$59,359
JardianceEmpagliflozin38$54,881
OzempicSemaglutide30$48,921
EliquisApixaban34$44,748
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$34,611
MounjaroTirzepatide16$27,720
FarxigaDapagliflozin Propanediol20$26,579
JanuviaSitagliptin Phosphate19$24,885
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$9,075
Rosuvastatin Calcium204$4,100
Atorvastatin Calcium245$3,779
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$3,766
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen177$3,470
Solifenacin Succinate17$3,411
Levothyroxine Sodium275$3,204

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$15$87,08060 claims
Boehringer IngelheimJardiance$30$54,88138 claims
Novo NordiskOzempic$246$48,92130 claims
PfizerEliquis, Prempro$92$47,12145 claims
GSKTrelegy Ellipta, Anoro Ellipta$14$43,68637 claims
AstraZenecaFarxiga$93$26,57920 claims
MerckJanuvia$52$24,88519 claims
AbbVieArmour Thyroid$62$1,65523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Gaylord

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →